The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

While Sarepta has now consented to the FDA’s request to stop selling Elevidys, the company’s brief standoff with the agency ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

The FDA subsequently issued is Class I risk classification on July 3. Vita Warehouse Corp. issued a voluntary recall for more than 40,000 bottles of Vitamin B12 supplements on June 12 because of ...

New data have further strengthened the link between human immune globulin products and the risk for thrombosis, prompting action by the US Food and Drug Administration (FDA). "Additional caution ...

In a major policy change, the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.

WASHINGTON (CNN/CNN Newsource/WKRC) — The Food and Drug Administration has expanded the heart risk warnings connected to COVID-19 shots. The Food and Drug Administration (FDA) has announced that ...